Lawrence L. Horstman

No ORCID on file · 8 papers in corpus · active 1993-2017

Study types

  • article 6
  • letter 1
  • review 1
article 2017
Unusual Long Term Remission in Multiple Myeloma Using Conventional Therapy Combined with Danazol
·doi:10.1182/blood.v130.suppl_1.5423.5423

Abstract Introduction and Case studies. The treatment of multiple myeloma (MM) has drastically changed over the past decade with significantly improved progression free as well as overall survival. Despite the advent of multiple treatment o…

article 2011
Danazol therapy combined with intermittent application of chemotherapy induces lasting remission in myeloproliferative disorder (MPD): an alternative for the elderly with advanced MPD
·doi:10.1179/102453311x12902908412075

There is no good alternative therapy available for elderly patients with advanced myeloproliferative disorders (MPD) who failed on conventional therapies and are not candidates for bone marrow transplant. We report here an effective therapy…

article 2006
Danazol with Intermittent Chemotherapy Induces Lasting Remissions in Advanced and Refractory MPD in Elderly Patients.
·doi:10.1182/blood.v108.11.4887.4887

Abstract BACKGROUND: Myeloproliferative disorders (MPD) are a group of chronic proliferations of mutated stem cells leading to bone marrow failure and extramedullary hematopoiesis with splenomegaly. Although bone marrow transplant can be an…

article 2005
Life-Threatening Hypercoagulable State Following Splenectomy in ITP: Successful Management with Aggressive Antithrombotic Therapy and Danazol
·doi:10.1177/107602960501100316

A life-threatening hypercoagulable state (HCS) is reported that developed after splenectomy in idiopathic thrombocytopenic purpura (ITP). A 50-year-old active male was rejected for blood donation because of an incidental finding of low plat…

review 1997
Danazol for paroxysmal nocturnal hemoglobinuria
·doi:10.1002/(sici)1096-8652(199702)54:2<149::aid-ajh9>3.0.co;2-x

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal stem-cell disorder in which blood cells lack complement inhibiting membrane proteins, and become susceptible to complement-mediated injury, leading to chronic intravascular hemolysi…

article 1997
Danazol for paroxysmal nocturnal hemoglobinuria
·doi:10.1002/(sici)1096-8652(199702)54:2<149::aid-ajh9>3.3.co;2-n

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal stem-cell disorder in which blood cells lack complement inhibiting membrane proteins, and become susceptible to complement-mediated injury, leading to chronic intravascular hemolysi…

article 1996
Danazol relieves refractory pruritus associated with myeloproliferative disorders and other diseases
·doi:10.1002/(sici)1096-8652(199602)51:2<112::aid-ajh3>3.0.co;2-0

Severe pruritus is frequently associated with myeloproliferative and other systemic illnesses, and often fails to respond to conventional measures. We used danazol (Danocrine), a synthetic attenuated androgen, in the treatment of severe pru…

letter 1993
Danazol for Henoch-Schonlein Purpura
·doi:10.7326/0003-4819-118-10-199305150-00021

Letters15 May 1993Danazol for Henoch-Schonlein PurpuraYoung J. Lee, MD, Lawrence L. Horstman, MD, and Yeon S. Ahn, MDYoung J. Lee, MDSearch for more papers by this author, Lawrence L. Horstman, MDSearch for more papers by this author, and Y…